Forma Therapeutics Holdings Inc

-0.55 (-3.53%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)689.63M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$10 Million
Adjusted EPS-$0.81
See more estimates
10-Day MA$15.35
50-Day MA$18.32
200-Day MA$24.39
See more pivots

Forma Therapeutics Holdings Inc Stock, NASDAQ:FMTX

300 North Beacon Street, Suite 501, Watertown, Massachusetts 02472
United States of America
Phone: +1.617.679.1970
Number of Employees: 107


Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA.